However, multivariate analysis showed that LURD was not an independent risk factor for AR (after adjustment for the recipient and donor age, sex, immunosuppression induction regimen, previous time on kidney replacement therapy (KRT), type of previous KRT, re-transplantation rate, donor eGFR, the prevalence of HLA-A MM, HLA-B-MM, and receptor BMI) (Table 3). This evidence concerns the gene HLA-B and Miyoshi myopathy.